FDA releases update on breast implant lymphoma risk
The U.S. Food and Drug Administration (FDA) on March 21 released an update...Read more on AuntMinnie.comRelated Reading: FDA issues update on cancer linked to breast implants Use MRI to diagnose PIP breast implant ruptures, Dutch say MRI adds to cancer detection in women with breast implants Unusual breast implant sensations while flying: Mystery solved Radiotherapy complicates implant-based breast reconstruction
(Natural News) A 48-year-old British woman survived a rare blood cancer that was triggered by her breast implants. Known as anaplastic large cell lymphoma (ALCL), this type of cancer is said to be a result of a reaction between the white blood cells and the new generation of rough surfaced breast implants introduced a decade...
CONCLUSION: In the literature, some articles describe correlation between connective tissue diseases and silicone breast implants, but the pathogenetic mechanisms are unknown. We report a rare case of breast morphea after positioning a silicone implant in a patient who had undergone mastectomy. This clinical report represents an interesting model of multidisciplinary management of a patient with breast cancer who developed an uncommon dermatologic disease. Further studies are needed to clarify the association between silicone implants and breast morphea. PMID: 29714655 [PubMed - as supplied by publisher]
Women with breast implants have an increased risk of a type of lymphoma that can usually be cured by surgery alone — but not always.
ConclusionsThe epidemiology of the disease strongly suggests that the vast majority of cases are not a cancer that will inevitably progress without treatment. The findings presented in the manuscript provide supportive clinical evidence. Consequently, an alternative view of BIA-ALCL with implications for research, diagnosis and clinical management needs to be considered.Level of Evidence IVThis journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266.
Women who get breast implants may be more likely to develop anaplastic large-cell lymphoma, a small Dutch study suggests.Reuters Health Information
(Reuters Health) - Women who get breast implants may be more likely to develop a rare type of cancer known as anaplastic large cell lymphoma, a small Dutch study suggests.
Health officials aren't recommending people have their breast implants removed after the Canadian government released its safety review on cases of implant-associated anaplastic large cell lymphoma (BIA-ALCL).
FRIDAY, Oct. 20, 2017 -- A particular breast implant may be associated with a rare type of cancer, researchers report. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is estimated to affect 1 in 30,000 women each year, but...
(Natural News) Since the year began, two women in the U.K. have died from cancer after receiving breast implants, revealed the Medicines and Healthcare Products Regulatory Agency (MHRA). The organization has reported another 23 cases of women who’ve developed the same type of cancer: anaplastic large cell lymphoma (ALCL). The disease is a rare type...
Two women died from anaplastic large cell lymphoma after being fitted with textured surface implants, the medicines watchdog MHRA has revealed.